- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: MF59 Adjuvant.
Displaying page 1 of 1.
EudraCT Number: 2009-013671-21 | Sponsor Protocol Number: V111_02 | Start Date*: 2009-08-27 |
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | ||
Full Title: A Randomized, Single-blind, Dose-Ranging, Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of Adjuvanted and non Adjuvanted Egg-Derived, Inactivated Novel Swine O... | ||
Medical condition: Pandemic influenza | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) DE (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-002602-20 | Sponsor Protocol Number: V104P2 | Start Date*: 2008-09-30 | |||||||||||
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | |||||||||||||
Full Title: A Phase Ib, Randomized, Observer-Blind, Multicenter, Factorial-Design Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Injections of Trivalent Inactivated Influenza Vaccine with... | |||||||||||||
Medical condition: seasonal influenza | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005107-24 | Sponsor Protocol Number: V112_06 | Start Date*: 2014-12-04 |
Sponsor Name:Novartis Vaccines and Diagnostics | ||
Full Title: Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1) 2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months | ||
Medical condition: Prophylaxis of A (H1N1) 2009 Pandemic Influenza | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2009-013639-39 | Sponsor Protocol Number: V110_03 | Start Date*: 2009-07-29 |
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | ||
Full Title: A Randomized, Single-blind, Dose-Ranging, Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of Adjuvanted and non Adjuvanted Cell-Derived, Inactivated Novel Swine ... | ||
Medical condition: Pandemic influenza | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-013672-45 | Sponsor Protocol Number: V111_03 | Start Date*: 2009-08-27 |
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | ||
Full Title: A Randomized, Single-blind, Dose-Ranging Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted and non-Adjuvanted Egg-derived, Inactivated Novel Swine... | ||
Medical condition: Pandemic influenza | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) DE (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-013640-37 | Sponsor Protocol Number: V110_04 | Start Date*: 2009-07-31 |
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | ||
Full Title: A Randomized, Single-blind, Dose-Ranging Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of Adjuvanted and non Adjuvanted Cell-derived, Inactivated Novel Swine O... | ||
Medical condition: Pandemic influenza | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) NL (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012394-35 | Sponsor Protocol Number: CCAD106A2203 | Start Date*: 2010-03-24 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 90-week, multi-center, randomized, double-blind, placebo-controlled study in patients with mild Alzheimer’s Disease (AD) to investigate the safety, tolerability and Abeta-specific antibody respon... | |||||||||||||
Medical condition: Alzheimer's Disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) SE (Completed) ES (Completed) DE (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002443-26 | Sponsor Protocol Number: OVG2012/04 | Start Date*: 2012-08-17 |
Sponsor Name:University of Oxford | ||
Full Title: A phase II, multi-centre, open labelled randomised control trial to describe immune & transcriptomic responses to trivalent inactivated vaccine (TIV) & MF59 adjuvanted influenza vaccine (ATIV) in 1... | ||
Medical condition: Healthy children will be immunised with two vaccines against influenza: Agrippal or Imuvac, or Fluad to study the immune responses to immunisation at a genetic level. | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005185-30 | Sponsor Protocol Number: V112_04 | Start Date*: 2014-12-05 |
Sponsor Name:Novartis Vaccines and Diagnostics | ||
Full Title: A Randomized, Open Label, Single Center, Dose- and Regimen-Ranging Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted and Non-Adjuvanted Egg-Derive... | ||
Medical condition: Prophylaxis of A(H1N1) 2009 Pandemic Influenza | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-005106-38 | Sponsor Protocol Number: V112_02 | Start Date*: 2014-12-04 |
Sponsor Name:Novartis Vaccines and Diagnostics | ||
Full Title: A Pivotal Randomized, Single-Blind, Dose-Finding Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted and Non-Adjuvanted Egg-Derived, Inactivated Nov... | ||
Medical condition: Prophylaxis of A (H1N1) 2009 Pandemic Influenza | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2016-001898-32 | Sponsor Protocol Number: V87_30 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Seqirus UK Limited | |||||||||||||
Full Title: A Phase 2, Randomized, Observer-Blind, Multicenter Study to Evaluate the Immunogenicity and Safety of Several Doses of Antigen and MF59 Adjuvant Content in a Monovalent H5N1 Pandemic Influenza Vacc... | |||||||||||||
Medical condition: Prophylaxis for Influenza virus | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.